Yaning Yang
0000-0003-2651-8222
2 papers found
Refreshing results…
Possibility of brigatinib‐based therapy, or chemotherapy plus anti‐angiogenic treatment after resistance of osimertinib harboring EGFR T790M‐ cis ‐C797S mutations in lung adenocarcinoma patients
The value of blood biomarkers of progression and prognosis in ALK‐positive patients with non–small cell lung cancer treated with crizotinib
Missing publications? Search for publications with a matching author name.